Autophagy inhibition improves sensitivity to the multi-kinase inhibitor regorafenib in preclinical mouse colon tumoroids

Written By Alicia Cokaiko

Agostini G, Leprovots M, Jeandriens J, Lefort A, Libert F, Sclafani F, Langer I, Hendlisz A, Garcia MI. (2025)

https://doi.org/10.3389/fcell.2025.1631116

Alicia Cokaiko
Previous

Transcriptomics of autoimmune diseases identifies FGFR1 as a target for pancreatic β-cell protection
Next

Microphysiological Systems in Cancer Research: Advancing Immunotherapy through Tumor Microenvironment-Integrated Organ-On-Chip Models. Adv. Ther